CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-25 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Durso Jerome Benedict Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Lawver Teri L Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Jorkasky Diane Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Schafer Klaus Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | SAYARE MITCHEL Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Hodges Philip Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-25 | Pisano Wayne Director | Grant or award · Stock Options (option to buy) | +48,800 | 48,800 | ||
| 2025-09-16 | Richardson Linda M Chief Commercial Officer | Grant or award · Stock Options (option to buy) | +278,000 | 278,000 | ||
| 2025-09-16 | Richardson Linda M Chief Commercial Officer | Grant or award · Restricted Stock Units | +96,000 | 96,000 | ||
| 2025-07-31 | Jordt Raymond M Chief Business Officer | Grant or award | +1,368 | $3.14 | $4K | 36,270 |
| 2025-07-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +2,018 | $3.14 | $6K | 16,087 |
| 2025-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +846 | $3.14 | $3K | 74,066 |
| 2025-03-17 | Sohn Catherine A. Director | Purchase | +1,000 | $5.78 | $6K | 1,000 |
| 2025-03-13 | WEAVER GREGORY L Chief Financial Officer | Purchase | +10,000 | $5.20 | $52K | 10,000 |
| 2025-03-07 | Harris Matthew Scott Chief Medical Officer | Gift | −67,787 | 14,069 | ||
| 2025-02-24 | Lawver Teri L Director | Grant or award · Stock Options (option to buy) | +69,800 | 69,800 | ||
| 2025-02-24 | Durso Jerome Benedict Director | Grant or award · Stock Options (option to buy) | +69,800 | 69,800 | ||
| 2025-02-06 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +18,600 | 18,600 |
Page 5 of 21 · 403 trades